Santa Cruz Biotechnology

Mdr (G-1)

#sc-13131 · western blot

30
Citing papers
1.3k
Combined citations
Supplier page Find this product

Research areas

Drug Transport and Resistance Mechanisms12RNA Interference and Gene Delivery4DNA Repair Mechanisms4Cancer-related Molecular Pathways4Histone Deacetylase Inhibitors Research3Cancer therapeutics and mechanisms3MicroRNA in disease regulation3Cancer, Hypoxia, and Metabolism2

Papers citing this product

1
Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment
EBioMedicine·2016·142 cit.·DOI
2
Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer
Frontiers in Oncology·2019·133 cit.·DOI
3
Myricetin induces apoptosis and enhances chemosensitivity in ovarian cancer cells
Oncology Letters·2017·69 cit.·DOI
4
Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter
Oncotarget·2015·67 cit.·DOI
5
miR‑30 decreases multidrug resistance in human gastric cancer cells by modulating cell autophagy
Experimental and Therapeutic Medicine·2017·64 cit.·DOI
6
miR‐495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression
Journal of Cellular and Molecular Medicine·2017·63 cit.·DOI
7
WT1-AS promotes cell apoptosis in hepatocellular carcinoma through down-regulating of WT1
Journal of Experimental & Clinical Cancer Research·2015·61 cit.·DOI
8
Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway
Oncotarget·2014·60 cit.·DOI
9
The medicinal plant goldenseal is a natural LDL-lowering agent with multiple bioactive components and new action mechanisms
Journal of Lipid Research·2006·59 cit.·DOI
10
Human Mesenchymal Stem Cells Are Resistant to Paclitaxel by Adopting a Non-Proliferative Fibroblastic State
PLoS ONE·2015·57 cit.·DOI
Mdr (G-1) — Evidence — PubIndex